Advertisement

Index by author

November 01, 1999; Volume 291,Issue 2

  1. Rosenstein, Björn

    1. ATP-Sensitive Potassium Channel Blocker HMR 1883 Reduces Mortality and Ischemia-Associated Electrocardiographic Changes in Pigs with Coronary Occlusion
      Klaus J. Wirth, Björn Rosenstein, Jörg Uhde, Heinrich C. Englert, Andreas E. Busch and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 474-481;

  2. Ross, Stephen T.

    1. Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis
      Michael W. Lark, George B. Stroup, Shing Mei Hwang, Ian E. James, David J. Rieman, Fred H. Drake, Jeremy N. Bradbeer, Ashwini Mathur, Karl F. Erhard, Kenneth A. Newlander, Stephen T. Ross, Kevin L. Salyers, Brian R. Smith, William H. Miller, William F. Huffman and Maxine Gowen
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 612-617;

  3. Rubio, Carlos

    1. Beneficial Effects of Ropivacaine in Rat Experimental Colitis
      Titti Martinsson, Tryggve Ljung, Carlos Rubio and Per M. Hellström
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 642-647;

  4. Rushmore, Thomas H.

    1. Role of a Potent Inhibitory Monoclonal Antibody to Cytochrome P-450 3A4 in Assessment of Human Drug Metabolism
      Qin Mei, Cuyue Tang, Carol Assang, Yuh Lin, Donald Slaughter, A. David Rodrigues, Thomas A. Baillie, Thomas H. Rushmore and Magang Shou
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 749-759;

  5. Sabban, Esther L.

    1. Nicotine Infusion Modulates Immobilization Stress-Triggered Induction of Gene Expression of Rat Catecholamine Biosynthetic Enzymes
      Lidia Serova, Emil Danailov, Firas Chamas and Esther L. Sabban
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 884-892;

  6. Sagawa, Toshio

    1. Selectivities of Dihydropyridine Derivatives in Blocking Ca2+ Channel Subtypes Expressed in XenopusOocytes
      Taiji Furukawa, Takeshi Yamakawa, Takayuki Midera, Toshio Sagawa, Yasuo Mori and Toshihide Nukada
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 464-473;

  7. Sai, Yoshimichi

    1. Na+-Dependent Carnitine Transport by Organic Cation Transporter (OCTN2): Its Pharmacological and Toxicological Relevance
      Rikiya Ohashi, Ikumi Tamai, Hikaru Yabuuchi, Jun-Ichi Nezu, Asuka Oku, Yoshimichi Sai, Miyuki Shimane and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 778-784;

  8. Saito, Hideyuki

    1. Recognition of l-Amino Acid Ester Compounds by Rat Peptide Transporters PEPT1 and PEPT2
      Kyoko Sawada, Tomohiro Terada, Hideyuki Saito, Yukiya Hashimoto and Ken-Ichi Inui
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 705-709;

  9. Salata, Joseph J.

    1. Modification of Cardiac Na+ Current by RWJ 24517 and Its Enantiomers in Guinea Pig Ventricular Myocytes
      Robert G. Tsushima, James E. Kelly, Joseph J. Salata, Kristine N. Liberty and J. Andrew Wasserstrom
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 845-855;

  10. Salyers, Kevin L.

    1. Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis
      Michael W. Lark, George B. Stroup, Shing Mei Hwang, Ian E. James, David J. Rieman, Fred H. Drake, Jeremy N. Bradbeer, Ashwini Mathur, Karl F. Erhard, Kenneth A. Newlander, Stephen T. Ross, Kevin L. Salyers, Brian R. Smith, William H. Miller, William F. Huffman and Maxine Gowen
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 612-617;
« Previous (Pages : 22 23 24 25 26 27 28 29 30 31 ... 35) Next »
Back to top

In this issue

Advertisement